Home
About us
Lead Compound: SNF472
- Indications
- Mechanism of action
News and Events
- News
- Events
Compassionate Use
Contact

01 10 2012

Meet Sanifit at Bio-Europe 2012 (Hamburg, Germany, November 12th-14th)

Our CEO, Dariusch Mani, will represent Sanifit at the Bio-Europe 2012.
Arrange a meeting through partnering system.

SANIFIT will attend SACHS Biotech Investor Forum in Zurich (October, 1st-2nd) FDA grants Sanifit Orphan Drug Designation for SNF472 for the treatment of calciphylaxis (CUA)

Recent Posts

Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
Data from SNF472 Phase 1b Clinical Trial published in British Journal of Clinical Pharmacology
Sanifit highlights publication of “50 Key Questions on Calciphylaxis”
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
Sanifit announces completion of enrollment in CaLIPSO – its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis

Categories

Important News
News

Archive

2019
2018
2017
2016
2015
2014
2013
2012
2011

© Sanifit 2019

Privacy and Cookies Policy | Credits IT2B

Subscribe to our Newsletter and Press Release

Please leave this field empty.

×

In accordance with the Data Protection General Regulation (hereinafter, DPGR) and the Spanish applicable regulations on Personal Data Protection, we inform you that your personal data will be included in the file number 2170181120, registered within the Spanish Data Protection Agency by Sanifit Therapeutics S.A., in order to be able to comply with our duties under the relationship we maintain with you. In order to fulfil our legal obligations concerning personal data protection, we inform you about the following details of the file:

Data Protection Basic Information

Controller Sanifit Therapeutics S.A.
Purpose Reply to the data subject’s request.
Legitimacy Data subject’s consent
Recipients The data will be subject to international transfer. In particular, to Laboratoris Sanifit Inc, the subsidiary company of Sanifit Therapeutics S.A. in the United States of America.
Rights Rights to access, rectify and delete the personal data, as well as the rights established in the additional information.

Data Protection Additional Information

Controller
Data Controller of your personal data:
Name: Sanifit Therapeutics S.A.
Address: ParcBIT – Ctra. Valldemossa, km7.4, Building Europa, 2nd Floor, 07121, Palma de Mallorca, Spain
E-mail: info@sanifit.com
----
Representative of the Data Controller of your personal data:
Name: Antonio C. Jiménez Abraham
Address: ParcBIT – Ctra. Valldemossa, km7.4, Building Europa, 2nd Floor, 07121, Palma de Mallorca, Spain
E-mail: info@sanifit.com

Purpose
Sanifit Therapeutics S.A. stores and processes your personal data in order to answer to your request or, if requested by you, to process your subscription to our newsletter.
The personal data shall be stored as long as allowed by the Spanish legislation.
Your data will not be used to take automated decisions.

Legitimacy
Data subject’s consent.
The personal data must be provided in order to answer to your request.

Recipients
The personal data will be transferred to the advertising agency in charge of the mailings of Sanifit Therapeutics S.A.
The personal data will be transferred abroad the European Union to Sanifit Inc., the subsidiary of Sanifit Therapeutics S.A.in the United States of America. Sanifit Inc is binded by an agreement with Sanifit Therapeutics S.A. with standard data protection clauses approved by the Data Protection European Committee. Should you be interested in receiving a copy of such Agreement, you should request it by sending an email to our email address info@sanifit.com

Rights
You have the right to Access your personal data, i.e. you shall have the right to address Sanifit Therapeutics S.A.. in order to request the following information: (i) whether the personal data are being processed, (ii) the purpose of such processing and (iii) information concerning the origin of the data and the transfers to third parties that have been made or that are planned to be made.
You have the right to rectification of the inaccurate data or, when appropriate, to request the deletion when, among other reasons, the data is not necessary any more for the purposes for which it was collected.
You might have the right to request the limitation of the processing of your data in certain circumstances, in which case Sanifit Therapeutics S.A. shall only maintain the data needed for exercise or defence of claims.
In certain circumstances, and for particular personal reasons, you have the right to oppose to the processing of your personal data. Sanifit Therapeutics S.A. shall cease on the processing unless there are legitimate ground not to or in case it is required for exercise or defence of claims.
You shall have the right of portability of your data, i.e. to the extent technically feasible, your personal data that has been stored by us may be directly transferred from us to another data controller upon request.
You have the right to withdraw consent.
You have the right to claim within the Spanish Data Protection Agency.

More information
Your personal data will be included in the file number 2170181120, registered by Sanifit Therapeutics S.A. within the Spanish Data Protection Agency, in order to fulfil the commitments resulting from our relationship with you.
The personal data that we store and process are of basic category and, as a consequence, Sanifit Therapeutics S.A. shall apply the basic security measures established in the Spanish data protection legislation in force.

*Please accept the terms in order to send your message.

Sello PYME INNOVADORA 30/06/2020

PYME INNOVADORA

Válido hasta el 30 de junio de 2020

escudo de MEIC 30/06/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok Read more